PACE (Pathways to Antimicrobial Clinical Efficacy)
United Kingdompaceamr.org.uk
Overview
PACE (Pathways to Antimicrobial Clinical Efficacy) is a UK-based public-private partnership that provides grant funding and support to accelerate early-stage innovation in antimicrobial resistance (AMR) research and development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Innovative Diagnostics | Nov 2025 | Grant | Co-investor |
| Immunethep | Apr 2025 | Grant | Co-investor |
| Oxford Drug Design | Feb 2025 | Grant | Co-investor |
| PhalconBio GmbH | Feb 2025 | Grant | Lead |
| Infex Therapeutics | Feb 2025 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
